Surgery Partners Stock Price Prediction

SGRY Stock  USD 26.33  0.39  1.50%   
At this time, the relative strength index (RSI) of Surgery Partners' share price is approaching 43. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Surgery Partners, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
Surgery Partners stock price prediction is an act of determining the future value of Surgery Partners shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Surgery Partners' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Surgery Partners and does not consider all of the tangible or intangible factors available from Surgery Partners' fundamental data. We analyze noise-free headlines and recent hype associated with Surgery Partners, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Surgery Partners' stock price prediction:
EPS Estimate Next Quarter
0.12
EPS Estimate Current Year
1
EPS Estimate Next Year
1.28
Wall Street Target Price
42.36
EPS Estimate Current Quarter
0.38
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Surgery Partners based on different types of headlines from major news networks to social media. The Surgery stock price prediction module provides an analysis of price elasticity to changes in media outlook on Surgery Partners over a specific investment horizon. Using Surgery Partners hype-based prediction, you can estimate the value of Surgery Partners from the perspective of Surgery Partners response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Surgery Partners using Surgery Partners' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Surgery using crowd psychology based on the activity and movement of Surgery Partners' stock price.

Surgery Partners Short Interest

A significant increase or decrease in Surgery Partners' short interest from the previous month could be a good indicator of investor sentiment towards Surgery. Short interest can provide insight into the potential direction of Surgery Partners stock and how bullish or bearish investors feel about the market overall. An investor who is long Surgery Partners may also wish to track short interest. As short interest increases, investors should be becoming more worried about Surgery Partners and may potentially protect profits, hedge Surgery Partners with its derivative instruments, or be ready for some potential downside.
200 Day MA
32.0427
Short Percent
0.1699
Short Ratio
9.68
Shares Short Prior Month
M
50 Day MA
30.268

Surgery Partners Hype to Price Pattern

Investor biases related to Surgery Partners' public news can be used to forecast risks associated with an investment in Surgery. The trend in average sentiment can be used to explain how an investor holding Surgery can time the market purely based on public headlines and social activities around Surgery Partners. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Surgery Partners' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Surgery Partners.

Surgery Partners Implied Volatility

    
  0.0  
Surgery Partners' implied volatility exposes the market's sentiment of Surgery Partners stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Surgery Partners' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Surgery Partners stock will not fluctuate a lot when Surgery Partners' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Surgery Partners. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Surgery Partners to buy its stock at a price that has no basis in reality. In that case, they are not buying Surgery because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Surgery Partners after-hype prediction price

    
  USD 26.11  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Surgery Partners Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Surgery Partners' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
23.7033.2635.86
Details
Naive
Forecast
LowNextHigh
21.3823.9826.58
Details
11 Analysts
Consensus
LowTargetHigh
42.5746.7851.93
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.020.080.12
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Surgery Partners. Your research has to be compared to or analyzed against Surgery Partners' peers to derive any actionable benefits. When done correctly, Surgery Partners' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Surgery Partners.

Surgery Partners After-Hype Price Prediction Density Analysis

As far as predicting the price of Surgery Partners at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Surgery Partners or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Surgery Partners, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Surgery Partners Estimiated After-Hype Price Volatility

In the context of predicting Surgery Partners' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Surgery Partners' historical news coverage. Surgery Partners' after-hype downside and upside margins for the prediction period are 23.51 and 28.71, respectively. We have considered Surgery Partners' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
26.33
26.11
After-hype Price
28.71
Upside
Surgery Partners is very steady at this time. Analysis and calculation of next after-hype price of Surgery Partners is based on 3 months time horizon.

Surgery Partners Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Surgery Partners is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgery Partners backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Surgery Partners, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.26 
2.60
  0.22 
  0.05 
9 Events / Month
8 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
26.33
26.11
0.84 
305.88  
Notes

Surgery Partners Hype Timeline

Surgery Partners is at this time traded for 26.33. The entity has historical hype elasticity of -0.22, and average elasticity to hype of competition of -0.05. Surgery is projected to decline in value after the next headline, with the price expected to drop to 26.11. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.84%, whereas the daily expected return is at this time at -0.26%. The volatility of related hype on Surgery Partners is about 1248.91%, with the expected price after the next announcement by competition of 26.28. About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.68. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 0.09. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 9 days.
Check out Surgery Partners Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Surgery Partners Related Hype Analysis

Having access to credible news sources related to Surgery Partners' direct competition is more important than ever and may enhance your ability to predict Surgery Partners' future price movements. Getting to know how Surgery Partners' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Surgery Partners may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PNTGPennant Group 0.51 10 per month 1.49  0.16  3.45 (3.21) 13.54 
ENSGThe Ensign Group(0.14)10 per month 1.13 (0) 2.38 (2.33) 7.13 
EHCEncompass Health Corp 1.27 10 per month 0.70  0.13  2.76 (1.43) 7.95 
HCSGHealthcare Services Group(0.04)8 per month 1.38  0.05  2.92 (2.78) 30.35 
EHABEnhabit(0.25)7 per month 2.97 (0.01) 5.48 (4.79) 27.98 
INNVInnovAge Holding Corp(0.15)11 per month 0.00 (0.15) 6.98 (8.20) 21.11 
NHCNational HealthCare(0.53)10 per month 0.00 (0.1) 2.18 (2.67) 7.84 
SEMSelect Medical Holdings 0.37 10 per month 1.39  0.03  2.43 (2.34) 12.75 
CCMConcord Medical Services 0.01 9 per month 0.00 (0.05) 11.54 (12.33) 55.56 
UHSUniversal Health Services(0.54)10 per month 1.22  0.04  2.43 (2.40) 7.40 
ADUSAddus HomeCare(2.80)10 per month 1.55  0.04  3.66 (2.49) 10.10 

Surgery Partners Additional Predictive Modules

Most predictive techniques to examine Surgery price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Surgery using various technical indicators. When you analyze Surgery charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Surgery Partners Predictive Indicators

The successful prediction of Surgery Partners stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Surgery Partners, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Surgery Partners based on analysis of Surgery Partners hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Surgery Partners's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Surgery Partners's related companies.
 2023 2024 (projected)
Dividend Yield0.0015160.00144
Price To Sales Ratio1.461.52

Story Coverage note for Surgery Partners

The number of cover stories for Surgery Partners depends on current market conditions and Surgery Partners' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Surgery Partners is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Surgery Partners' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Surgery Partners Short Properties

Surgery Partners' future price predictability will typically decrease when Surgery Partners' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Surgery Partners often depends not only on the future outlook of the potential Surgery Partners' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Surgery Partners' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding125.6 M
Cash And Short Term Investments195.9 M
When determining whether Surgery Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Surgery Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surgery Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surgery Partners Stock:
Check out Surgery Partners Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Surgery Stock analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Surgery Partners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.09)
Revenue Per Share
21.839
Quarterly Revenue Growth
0.04
Return On Assets
0.0383
Return On Equity
0.0407
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.